Eaton-Cambridge’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Eaton-Cambridge's LLY Position: Q2 2026 in Review
Eaton-Cambridge increased its Eli Lilly (LLY) stake by 6.1% in Q2 2026, buying an estimated $54.2K and bringing the position to 927 shares worth $1.11M. The position accounts for 0.31% of the portfolio, ranked #22.
Eaton-Cambridge first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Eaton-Cambridge held 927 shares of Eli Lilly worth $1.11M as of Q2 2026.
- Eaton-Cambridge bought 53 Eli Lilly shares in Q2 2026, an estimated $54.2K.
- Eli Lilly made up 0.31% of Eaton-Cambridge's portfolio in Q2 2026, its #22 holding.
- Eaton-Cambridge first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Eaton-Cambridge's 13F filing for Q2 2026, filed 23 Jul 2026.